Skip to content
←Back to glossaryLife & protection

Excess medical fees and OPTAM (France)

Its 4 cross-references, woven across the glossary's 18 categories

The part of fees charged by some doctors above the social security tariff; the controlled pricing option commits doctors to moderate it, and conditions its reimbursement under responsible contracts.

Definition

In France, the national health insurance reimburses consultations on the basis of an agreed tariff. So-called sector 1 doctors apply this tariff; sector 2 doctors may set their own fees and charge an excess, which neither social security nor often the supplementary insurer fully reimburses. Excess fees are concentrated in certain specialties, surgery, gynecology, anesthesia, and certain cities, and account for a large part of patients' out-of-pocket costs. To moderate them, the medical agreement created in 2017 the controlled pricing option, which succeeded the 2013 access-to-care contract. A doctor who joins commits not to exceed an average excess rate and to perform a share of procedures at the base tariff; in exchange, the doctor's patients are better reimbursed. Responsible contracts organize the same sorting on the supplementary side: they may reimburse the excess fees of participating doctors, but must cap those of non-participants, at 100 percent of the base tariff and at a lower level than for participants. For health insurers, excess fees are a hard-to-control expense and a source of top-up contracts, which cover what the responsible contract is not allowed to reimburse.

Example

Hypothetical case, under the rule in force since 1 January 2017, when OPTAM replaced the contrat d'accès aux soins: a surgeon not in the option charges 900 euros for a procedure with a 300 euro base tariff. The patient's responsible contract can reimburse the excess only up to 100 percent of the base tariff, 300 euros: 300 euros remain for her to pay, unless she has a top-up contract.

Related terms
Stay informed

Follow the research

One letter a week. First, the week's underwriting note, when one is published: a dated, argued decision, signed by Paul Bernardski. Then what the observatory published on cyber risk, political risk and insurance. No account, no tracking.

No spam, one-click unsubscribe, no data ever sold.